How Chapters Health Supports Cancer Patients: Five Things to Know

by | Sep 9, 2021

The open access manager of Chapters Health explains the level of care and access cancer patients can expect when making the transition to hospice care.

What do you imagine when you think of a hospice setting? Comfort measures only? Pain management? No oncology treatments? It’s not always that simple and it’s one of the many myths about hospice care. Patients should not have to choose between their hospice benefits and treatment for their condition. That’s the philosophy behind open access and how Chapters Health System supports cancer patients.

So how does that philosophy apply to cancer patients who make the transition to our hospice services? What therapies can they continue under our care? In short… it depends. Every patient is different, and we evaluate it on a patient-to-patient basis. For many patients and families, this explanation is frustrating. In hopes of easing that frustration and simplifying the process, here are five things to know when considering hospice with Chapters Health.

1. Some chemotherapy and certain types of radiation are not off the table

There are different goals for every patient. Some would like to extend their life enough to reach a certain milestone. Others simply desire to have their symptoms managed and live out their lives as comfortable as possible. No matter what the goal is, it’s the duty of the hospice provider to allow the care to be patient driven.

For example, a patient with esophageal cancer may have a tumor pressing on the esophagus, preventing them from swallowing. There are of course ways to manage the patient’s pain, but should palliative chemotherapy or radiation be a consideration? If you can shrink that tumor and improve the patient’s ability to swallow, while allowing them to remain alert and interact with their family, you’ve accomplished the primary goal of hospice, which is improving a patient’s quality of life in the time they have left. There are so many ways chemotherapy, radiation and other therapies can aid in symptom management for hospice patients, as explained by Dr. Stewart Stein, Chapters Health vice president of medical services

According to a study in 2018, 76 palliative care, hospice and oncology providers at six VA Medical Centers agreed that the open access model of care proved to be the most beneficial for cancer patients with a prognosis of six months or less.

“Our open access in general is so broad,” said Terri Massaro, open access manager for Chapters Health. “Other hospices say they do open access, but nobody does it like we do. Depending on where our patient is in their disease process, there are many interventions that may be part of the hospice plan of care such as diagnostic scans, laboratory studies, artificial nutrition and hydration, and management of drains and tubes, just to name a few.”

2. The process is ultimately patient driven

What if a cancer patient and their oncologist insist chemotherapy is the best course? How does a hospice provider decide whether to continue supporting the care plan?  It boils down to whether the proposed therapy meets hospice guidelines and the functionality of the patient. Are they supporting their nutritional status? Is the patient ambulatory? Can they complete at least some activities of daily living (ADLs) without assistance? If the answer is yes to any of these questions, then there’s a greater chance Chapters Health can support the treatment.

However, the issue is never black and white. There are many areas of gray when it comes to how a hospice provider supports outside treatment for patients.

“The guidelines are not yes and no. It’s how can we safely meet your goals?” said Massaro. “Our patients are sometimes scared.  Most of them would like to remain in their home.  How can we help them meet that goal? How can we support them where they want to be?”

3. Participating in clinical trials does not rule out access to hospice care

No cancer patients go into a clinical trial not hoping they can be one of the examples where a drug has helped them or extended life. That’s just basic human nature. However, some families may believe that because their loved one is in a clinical trial that means they can’t receive hospice benefits. They’re not always right.

“These clinical trials are either existing drugs or new drugs where nobody is promising they’re going to get a cure,” said Massaro. “The trials are generally covering the costs of the drugs, the scans and other things that go along with that. If someone wants to participate in a clinical trial that may help them as well as contribute to a body of research that may also help someone else one day, we want to support that goal. “

4. The goal is to keep the cancer patients at home

Massaro said the goal is to keep a patient comfortable in their own home. That’s important to remember when understanding what treatments, a hospice provider can support.

“We always want to err on the side of supporting the patient. There are many side effects {of cancer treatment} that can be safely and effectively managed at home.  However, there are some treatments/side effects that are beyond the scope of what can be managed in the home.  That is why each therapy is carefully evaluated.”

But Massaro added many other treatments such as chemotherapy, blood infusions and certain types of radiation are manageable and commonly supported by Chapters Health because symptoms are manageable without requiring frequent hospitalization.

5. How is home health different from hospice for cancer patients?

The major benefit of hospice is a higher level of support provided to the patient and family. In home health you have less visits from clinicians and you don’t benefit from the services of a dedicated interdisciplinary group (IDG). This group consists of the clinicians you would normally see such as nursing assistants and nurses, but it also includes social workers, chaplains and volunteers.

Massaro also said home health is “objective based.” The patients generally have specific needs such as wound care, diabetes education or physical therapy following a surgery.  Once that objective is met, home health is generally discontinued, and the number of visits may be limited. It differs greatly for a hospice patient. The number of visits and who visits changes to meet the needs of the patient and family, whether they are medical, nursing, psychosocial or spiritual. Care is not discontinued if a patient continues to meet hospice criteria.

Chapters Health System is committed to serving the needs of its patients, families, caregivers, health providers, partners and communities. If you know someone who could use supportive care in the comfort of his or her home, please call our helpful Chapters Health team at 1.866.204.8611 or Contact Us.

Austin Mudd

Austin Mudd

Austin Mudd, Media Relations Specialist at Chapters Health System, is responsible for external communications for the nonprofit organization. Email: [email protected]

About Us

Established in 1983 as a community-centered, nonprofit entity, Chapters Health has grown exponentially through its radical approach to healthcare that leverages a one-of-a-kind system to support patients, families, and caregivers across the country, while remaining grounded in the mission of taking care of patients, or taking care of those who do®.

Learn More

Chapters Health System Announces Selection on Hospital and Health System CFOs to Know

Willamette Vital Health Finalizes Affiliation with Chapters Health System

Nathan Adelson Hospice Finalizes Affiliation with Chapters Health System

Andrew Molosky Makes Becker’s Hospital Review 2025 Great Leaders in Healthcare List

Andrew Molosky on podcast

John J. Whyte, MD, MPH

CEO and Executive President,
American Medical Association

John Whyte, MD, MPH serves as the CEO and Executive Vice President of the American Medical Association, the nation’s largest physician organization.

Prior to the AMA, Dr. Whyte served as the Chief Medical Officer at WebMD, leading initiatives that expanded strategic partnerships, created new business opportunities, and positioned WebMD at the forefront of digital health innovation. He was a pivotal force in evolving WebMD’s digital platforms from content delivery engines to powerful tools connecting consumers directly to care, establishing critical new revenue models. He is a recognized leader in healthcare delivery and regulation and is consistently named as one of the Top 20 Health Influencers.

Before joining WebMD, Dr. Whyte served as Director of Professional Affairs and Stakeholder Engagement at the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research. There, he spearheaded groundbreaking initiatives to modernize clinical trial design, expand diversity in research, and advance the regulatory use of real-world evidence — efforts that continue to impact patient-centered drug development today.

Earlier, as Chief Medical Expert and Vice President of Health and Medical Education at Discovery Channel, Dr. Whyte launched educational programming that captured both medical and mainstream audiences, successfully aligning mission-driven health education with corporate funding strategies and building new multimedia brand identities.

At the Centers for Medicare & Medicaid Services (CMS), Dr. Whyte played a pivotal role in formalizing Medicare’s national coverage decision process, directly shaping payment policies and advancing innovative models to improve healthcare outcomes. His experience at CMS demonstrates a deep understanding of health policy, reimbursement strategies, and the critical intersection of clinical innovation and payment models.

A board-certified internist, Dr. Whyte completed his MD at Hahnemann University School of Medicine, his residency at Duke University Medical Center and earned his MPH in Health Policy and Management at Harvard University. He previously served as a health services research fellow at Stanford University. An accomplished author, Dr. Whyte has written extensively for both professional and consumer audiences, including five best-selling book

Andrew Molosky on podcast

Dr. Venki Ramakrishnan

Nobel Laureate

Venki Ramakrishnan is an American and British molecular biologist who shared the 2009 Nobel Prize in Chemistry. He currently works at the world-renowned MRC Laboratory of Molecular Biology in Cambridge, England and from 2015-2020, he served as President of the Royal Society, one of the world’s oldest scientific organizations. He is best known for his work on protein synthesis, the process by which genetic information is used by the ribosome to make the thousands of proteins that make life possible. This process is fundamental to all life and its dysfunction leads to many diseases as well as to aging. He is a member of the US National Academy of Sciences and was knighted by the British government in 2012. In 2022, he received one of Britain’s highest civilian honors, the Order of Merit, which is restricted to 24 people across all fields.

In addition to his academic work, Ramakrishnan is a science partner of the venture capital fund Ahren Innovation Capital, and on the boards of the AI-based drug development company, Isomorphic Labs, and the British Library. He recently co-founded RNAvate, an RNA therapeutics company based on stable, next-generation RNA molecules. In the public arena, he played a leadership role when he was president of the Royal Society, including dealing with the consequences of Brexit and helping convene the Society’s response to provide advice during the covid pandemic and did a significant amount of public engagement including articles in the press and appearances on national media.

Ramakrishnan is the author of two popular books: Gene Machine (2018), a very frank scientific memoir about the race for the structure of the ribosome that led to the Nobel Prize; and Why We Die: The New Science of Aging and the Quest For Immortality (2024), which looks at the biology of aging and efforts to combat it.

Andrew Molosky on podcast

Marwa El-Menshawi, MD, MPH

Chief Operating Officer, PACE Chapters Health System

Marwa El-Menshawi, MD is the Chief Operating Office for Hope PACE. She is a triple board-certified physician, specializing in Family, Geriatric and Hospice Medicine. Dr. El-Menshawi's focus is on improving the lives of those affected by advanced age and serious illness through innovation in high complexity and value-based care. She has almost 20 years of clinical, academic and healthcare leadership experience.

Dr. El-Menshawi is a member of the American Academy of Family Medicine and the National PACE Association. She serves on the Mayor's Committee for Livability and Healthy Aging, focused on serving the community through advocacy and education, recommending and promoting programs and initiatives that benefit older adults.

Dr. El-Menshawi earned her Medical Doctorate as a Magna Cum Laude graduate from the University of Alabama School of Medicine and was awarded the distinguished membership into the Alpha Omega Alpha medical honors society, along with multiple academic achievement awards including the American Medical Women's Association Glasgow-Rubin Achievement Citation, the Merck Manual Award and the Peacock Teaching Fellowship. She completed her residency in Family Medicine and Certificate of Added Qualifications in Geriatric Medicine following a Geriatrics Fellowship at Advent Health in Orlando, FL. She serves as a Clinical Assistant Professor of Geriatrics at the Florida State University College of Medicine and an Assistant Professor of Family Medicine at the University of Central Florida College of Medicine.

Andrew Molosky on podcast

Andrew Molosky

President and CEO, Chapters Health System

Andrew Molosky is the President and Chief Executive Officer of Chapters Health System, the country's defining chronic illness organization, comprised of more than 30 different companies and programs, including the nation's largest nonprofit hospice network, PACE, value-based care such as CareNu, a Medicare Advantage plan, managed services organizations, technology solutions, advanced illness offerings, and more.
Established in 1983 as a community-centered, nonprofit entity, Chapters Health has grown exponentially through Molosky's innovative approach to healthcare, becoming a national leader recognized by Great Places to Work, Fortune, USA Today, and others for being a top place to work.
As a leading voice in healthcare, Molosky is routinely engaged as a consultant, speaker, and mentor. Molosky is modeling and leading across several industries concurrently.
Molosky has more than 20 years of experience spanning an array of geographies and organizations, including publicly traded, privately held, and nonprofit. He completed his undergraduate work at the University of Toledo and his Master of Business Administration from the Ken Blanchard College of Business at Grand Canyon University, additionally holding his Fellowship from the American College of Healthcare Executives.

Share This